| Normal cells and malignant cells transfected with the HRas oncogene have the same heat sensitivity in culture. | None |
| Identification of the principal promoter sequence of the c-H-ras transforming oncogene: deletion analysis of the 5 -flanking region by focus formation assay. | None |
| Activation of the human c-Ha-ras-1 proto-oncogene by in-vitro reaction with N-nitrosomethyl(acetoxymethyl)amine. | None |
| Expression of c-Myc, c-Myb, c-Erb-B and c-H-Ras oncogene mRNAs in fibroblasts cultured from psoriatic patients. | None |
| Different activities of the adenovirus types 5 and 12 E1A regions in transformation with the EJ Ha-ras oncogene. | None |
| Mitogenic effects of the proto-oncogene and oncogene forms of c-H-ras DNA in human diploid fibroblasts. | None |
| Malignant transformation of murine fibroblasts by a human c-Ha-ras-1 oncogene does not require a functional epidermal growth factor receptor. | None |
| Dose effects of transfected c-Ha-rasVal 12 oncogene in transformed cell clones. | None |
| Methionine metabolism defect in cells transfected with an activated HRAS1 oncogene. | None |
| Transforming activity of the c-Ha-ras oncogene having two point mutations in codons 12 and 61. | None |
| Transformation of human bronchial epithelial cells transfected by Harvey ras oncogene. | None |
| c-Ha-ras-1 proto-oncogene amplification and overexpression during the limited replicative life span of normal human fibroblasts. | None |
| Integration of a mutant c-Ha-ras oncogene into C3H/10T1/2 cells and its relationship to tumorigenic transformation. | None |
| Heterogeneity of cell lines derived after transformation of early passage rodent cells by the Ha-ras1 human oncogene. | None |
| Wilms tumor-aniridia association: segregation of affected chromosome in somatic cell hybrids, identification of cell surface antigen associated with deleted area, and regional mapping of c-Ha-ras-1 oncogene, insulin gene, and beta-globin gene. | None |
| Involvement of protease in L-glutamine control of nucleic acid and polyphosphate metabolism in cells transformed by 9,10-dimethyl-1,2-benzanthracene, SV40 and H-ras oncogene. | None |
| Mechanism of activation of a human oncogene. | None |
| Mutation affecting the 12th amino acid of the c-Ha-ras oncogene product occurs infrequently in human cancer. | None |
| Spontaneous activation of a human proto-oncogene. | None |
| Localization of c-ras oncogene family on human germ-line chromosomes. | None |